Cedar Mountain Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$177K Buy
1,216
+1
+0.1% +$138 0.03% 74
2026
Q2
$156K Buy
1,215
+297
+32% +$34.8K 0.03% 85
2026
Q1
$110K Buy
918
+248
+37% +$28.6K 0.02% 83
2025
Q4
$70.5K Hold
670
– – 0.01% 98
2025
Q3
$56.2K Buy
670
+646
+2,692% +$53.2K 0.01% 108
2025
Q2
$1.87K Buy
24
+1
+4% +$79 ﹤0.01% 305
2025
Q1
$2.1K Hold
23
– – ﹤0.01% 285
2024
Q4
$2.3K Hold
23
– – ﹤0.01% 305
2024
Q3
$2.61K Sell
23
-43
-65% -$5.11K ﹤0.01% 277
2024
Q2
$8.17K Buy
66
+43
+187% +$5.54K ﹤0.01% 200
2024
Q1
$3.04K Buy
+23
New +$2.84K ﹤0.01% 253
2022
Q4
– Sell
-136
Closed -$12K – 318
2022
Q3
$12K Buy
136
+1
+0.7% +$89 ﹤0.01% 146
2022
Q2
$12K Buy
135
+1
+0.7% +$89 ﹤0.01% 153
2022
Q1
$11K Buy
134
+1
+0.8% +$79 ﹤0.01% 168
2021
Q4
$10K Buy
133
+1
+0.8% +$80 ﹤0.01% 174
2021
Q3
$10K Buy
132
+1
+0.8% +$76 ﹤0.01% 167
2021
Q2
$10K Sell
131
-4
-3% -$298 ﹤0.01% 167
2021
Q1
$10K Buy
135
+1
+0.7% +$74 ﹤0.01% 175
2020
Q4
$11K Buy
134
+66
+97% +$5.05K ﹤0.01% 169
2020
Q3
$5K Buy
68
+1
+1% +$78 ﹤0.01% 190
2020
Q2
$5K Hold
67
– – ﹤0.01% 184
2020
Q1
$5K Buy
+67
New +$5.27K ﹤0.01% 160

Other funds holding MRK

Cedar Mountain Advisors's MRK Position: Q3 2026 in Review

Cedar Mountain Advisors increased its Merck (MRK) stake by 0.08% in Q3 2026, buying an estimated $138 and bringing the position to 1,216 shares worth $177K. The position accounts for 0.03% of the portfolio, ranked #74.

Cedar Mountain Advisors first reported a position in MRK in Q1 2020 and has held it in 22 quarters since. 1,788 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Cedar Mountain Advisors held 1,216 shares of Merck worth $177K as of Q3 2026.
  • Cedar Mountain Advisors bought 1 Merck share in Q3 2026, an estimated $138.
  • Merck made up 0.03% of Cedar Mountain Advisors's portfolio in Q3 2026, its #74 holding.
  • Cedar Mountain Advisors first reported a position in Merck in Q1 2020 and has held it in 22 quarters since.
  • 1,788 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Cedar Mountain Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.